TETRACORE INC has a total of 26 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and chemical engineering are BIO-RAD LABORATORIES INC, DIASORIN S P A and BELLBROOK LABS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 1 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Chemical engineering | |
#4 | Pharmaceuticals | |
#5 | Machines | |
#6 | Computer technology |
# | Name | Total Patents |
---|---|---|
#1 | Nelson William M | 9 |
#2 | Mangold Beverly L | 8 |
#3 | Aldrich Jennifer L | 7 |
#4 | O'Brien Thomas W | 7 |
#5 | De Vazeille Aymeric Randanne | 5 |
#6 | Almassian David R | 5 |
#7 | Armantrout Kyle | 5 |
#8 | Fecteau Tracy Calvin | 4 |
#9 | Kuserk Colin | 3 |
#10 | Nelson William Max | 3 |
Publication | Filing date | Title |
---|---|---|
US2018021026A1 | Self-contained sampling device for processing whole blood | |
US2017065980A1 | Self-metering of fluid into a reaction chamber | |
US2017065946A1 | Device and method for mixing and bubble removal | |
US2017044585A1 | Methods for temperature-mediated nested polymerase chain reaction | |
US2017046480A1 | Device and method for detecting the presence or absence of nucleic acid amplification | |
US2017044518A1 | Rapid solid phase extraction device and methods | |
US2006115908A1 | Multiplexed analyses of contaminant-laden gas in a particle impact collector | |
US2007231840A1 | Spore specific antigen | |
CN101031587A | Spore specific antibodies | |
US2005170335A1 | Detection of PRRSV | |
WO02095074A1 | Foot and mouth disease virus diagnostic and methods | |
EP1280828A2 | Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |